Profile

Oxford Cancer Analytics (OXcan) is creating a paradigm shift in early disease detection, monitoring, and treatment of lung cancer. OXcan’s multidisciplinary team invented a liquid biopsy blood test developed via cutting-edge proteomics and machine learning that can detect lung cancers early enough when they can still be cured. Fully integrated with existing clinical pathways for accelerated deployment and collaborating with 15+ leading centres of excellence across three continents, this blood test can be conducted in an affordable, minimally invasive, and routine manner in large populations with standard equipment in any diagnostics facility at 1/10th of the cost compared to conventional approaches.

Oxford Cancer Analytics Ltd. logo

Website

oxcan.org

Contact

Event details

Date: January 13 - 15, 2025

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

21 in total
  • 20/20 OptimEyes Technologies Inc.
    20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for…
  • AmacaThera
    AmacaThera is a venture-backed clinical stage biotechnology company supported by institutional investors…
  • Custom Biologics
    Custom Biologics is a regulatory compliant, large molecule bioanalytical…
  • Esphera SynBio
    Esphera SynBio is developing next-generation cancer and immunoregulatory treatments through its innovative…
  • Eurofins CDMO Alphora
    Eurofins CDMO Alphora Inc. provides integrated solutions for small molecules, drug product,…
  • GL Chemtec International Ltd.
    For over two decades, Toronto area-based GL CHEMTEC has been dedicated to delivering innovative…
  • HDAX Therapeutics
    HDAX Therapeutics is a biotechnology company pioneering a novel approach to targeting…
  • ImmunoBiochem Corporation
    ImmunoBiochem is an innovative, pharma-partnered biotech on a mission to develop novel bioconjugate therapeutics…
  • Inteligex Inc.
    Inteligex Inc. is a regenerative medicine company focused on improving clinical outcomes for patients with…
  • Iseehear Inc.
    Iseehear Inc. is a leading provider of comprehensive IT solutions for the biomedical research…
  • Mannin Research
    Mannin Research Inc. is a Canadian private biotechnology company, headquartered in Toronto, Ontario. It is…
  • Mediphage Bioceuticals Inc.
    Mediphage, a Toronto-based biotechnology company, has developed a proprietary and scalable manufacturing process…
  • Novel Biotechnologies Inc.
    Plasmid DNA is starting material for cell and gene, RNA and DNA therapies…
  • Nucro-Technics
    Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both…
  • Oxford Cancer Analytics Ltd.
    Oxford Cancer Analytics (OXcan) is creating a paradigm shift in early disease detection, monitoring…
  • Pattern Pharma Inc.
    Pattern Pharma’s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity by targeting…
  • ProteinQure Inc.
    ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead…
  • PurMindsNeuroPharma
    PurMinds NeuroPharma is a neuro-medicine development company pursuing breakthrough solutions for the treatment of…
  • QurCan Therapeutics Inc.
    QurCan Therapeutics is developing tissue and cell-targeted genetic medicine using its proprietary hybrid polymer-…
  • Spiderwort Inc.
    Spiderwort is a tissue engineering company that develops cellulose-based scaffolds for use in regenerative…
  • TheraVac Biologics
    TheraVac Biologics is developing novel vaccines and immunotherapies for aging-related diseases associated with…